Skip to main content
OLIPASS CORPORATION logo

OLIPASS CORPORATION — Investor Relations & Filings

Ticker · 244460 ISIN · KR7244460002 KO Professional, scientific and technical activities
Open in API
Filings indexed 505 across all filing types
Latest filing 2025-03-25 Regulatory Filings
Country KR South Korea
Listing KO 244460

About OLIPASS CORPORATION

https://www.olipass.com/front/eng/index…

OLIPASS CORPORATION is a research and development company focused on creating RNA therapeutics. The company's core activities are centered on its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. OPNA is a novel technology derived from Peptide Nucleic Acid (PNA) by introducing a cationic lipid moiety onto the nucleobase. This structural modification is designed to markedly improve cell permeability, a key challenge in nucleic acid-based drug delivery. The platform is optimized to induce exon skipping by specifically binding to target pre-mRNA inside the cell nucleus, enabling the discovery and development of new therapeutic candidates.

Recent filings

Filing Released Lang Actions
조회공시요구(현저한시황변동)
Regulatory Filings Classification · 100% confidence The document is a formal request from a regulatory body (exchange) to the company 'Olipass' regarding significant market fluctuations in its stock price. This is a standard regulatory inquiry requiring a response by a specific deadline. Since it is a regulatory announcement that does not fit into specific categories like earnings or dividends, it falls under the general regulatory filing category.
2025-03-25 Korean
기타경영사항(자율공시) (감사보고서 제출 지연)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Olipass regarding the delay in submitting their audit report. It is a formal disclosure of a corporate event (delay in audit report submission) required by the 'Act on External Audit of Stock Companies'. Since it does not fit into specific categories like financial reports, proxy statements, or dividend announcements, and is a formal regulatory disclosure, it falls under the 'Regulatory Filings' category.
2025-03-21 Korean
사업보고서제출기한연장신고서 (2024.12)
Report Publication Announcement Classification · 100% confidence The document is a formal 'Report Submission Deadline Extension Notice' (사업보고서제출기한연장신고서) filed by Olipass Co., Ltd. with the Financial Services Commission and the Korea Exchange. It explains that the company cannot meet the statutory deadline for filing its annual report due to delays in the audit process by its accounting firm (Samjong KPMG). Since this is a regulatory notification regarding a filing delay and does not constitute the annual report itself, it falls under the 'Regulatory Filings' category.
2025-03-21 Korean
기타주요경영사항 (주요사항보고서(유형자산양수결정) 철회)
Regulatory Filings Classification · 100% confidence The document is a formal regulatory filing from the company Olipass regarding the cancellation of a previously announced tangible asset acquisition. It details the withdrawal of a board resolution, the specific assets involved, the financial terms, and the reason for the cancellation. Since this is a specific corporate event announcement that does not fit into categories like M&A (which usually implies a merger or takeover), share issues, or dividends, it falls under the general regulatory filing category for material corporate events.
2025-03-20 Korean
[기재정정]주요사항보고서(유형자산양수결정)
M&A Activity Classification · 100% confidence The document is a regulatory filing (specifically a 'Correction Report' or 'Amendment') submitted to the Korea Exchange regarding a previous decision to acquire tangible assets. The content explicitly states that the company is withdrawing from a previously announced asset acquisition due to a contract termination notice. Since this is a formal regulatory disclosure regarding a material corporate event (cancellation of an asset acquisition) and does not fit into specific categories like M&A (which usually refers to company mergers/takeovers) or other specialized categories, it is classified as a general Regulatory Filing (RNS).
2025-03-20 Korean
기타주요경영사항 (채무인수결정 철회)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (Olipass) regarding the cancellation of a debt assumption decision. It is a formal disclosure of a material corporate event ('기타 주요경영사항'). Since it does not fit into specific categories like M&A, share issues, or financial reports, and is a standard regulatory disclosure of a business decision, it falls under the RNS (Regulatory Filings) category.
2025-03-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.